Compare · TMO vs ZBRA
TMO vs ZBRA
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Zebra Technologies Corporation (ZBRA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMO and ZBRA operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $225.01B, about 13.5x ZBRA ($16.61B).
- TMO has been more active in the news (16 items in the past 4 weeks vs 5 for ZBRA).
- Both have 25 recent analyst ratings on file.
- Company
- Thermo Fisher Scientific Inc
- Zebra Technologies Corporation
- Price
- -
- -
- Market cap
- $225.01B
- $16.61B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 1991
- News (4w)
- 16
- 5
- Recent ratings
- 25
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Zebra Technologies Corporation
Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers, which produce labels, wristbands, tickets, receipts, and plastic cards; RFID printers and encoders; accessories and options for its printers, including vehicle mounts and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution, as well as self-laminating wristbands for use in laser printers. It also provides a range of maintenance, technical support, repair, and managed and professional services; real-time location systems and services; and tags, sensors, exciters, middleware software, and application software, as well as physical inventory management solutions, and rugged tablets and enterprise-grade mobile computing products and accessories. In addition, the company offers barcode scanners, image capture devices, and RFID readers; and workforce management solutions, workflow execution and task management solutions, and prescriptive analytics solutions, as well as communications and collaboration solutions. The company serves retail and e-commerce, transportation and logistics, manufacturing, healthcare, hospitality, warehouse and distribution, energy and utilities, government, education, and banking enterprises. It sells its products, solutions, and services through distributors, value added resellers, independent software vendors, direct marketers, and original equipment manufacturers. The company was founded in 1969 and is headquartered in Lincolnshire, Illinois.
Latest TMO
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
Latest ZBRA
- Zebra Technologies to Present at Citi's 2026 Global Technology, Media & Telecom Conference
- University Health Deploys Zebra Mobile Devices to Reduce Callback Times and Modernize Workflows
- Zebra Technologies Wins Three Red Dot Design Awards for Devices Powering Frontline Workflows
- Director Connly Linda sold $188,840 worth of shares (500 units at $377.68), decreasing direct ownership by 12% to 3,708 units (SEC Form 4)
- Chief Strategy Officer Cho Michael sold $1,313,200 worth of shares (3,500 units at $375.20), decreasing direct ownership by 40% to 5,170 units (SEC Form 4)
- Chief People Officer Luff Loizides Melissa covered exercise/tax liability with 46 shares, decreasing direct ownership by 1% to 3,656 units (SEC Form 4)
- SEC Form 10-Q filed by Zebra Technologies Corporation
- Zebra Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zebra Technologies Announces Second Quarter 2026 Results
- Coordinated Robot Fleets Are Fast Becoming the Next Frontier in Autonomous Operations